National Cancer Plan

Baroness Laing of Elderslie Excerpts

Monday 10th February 2025 Lords Chamber

[Baroness Merron (Lab)]

I wish my noble friend well with his treatment. Screening for prostate cancer is not currently recommended in the UK because of the inaccuracy of the current best test available, which is the PSA. The advice we are given is that the PSA-based screening programme could harm men, as some could be diagnosed with a cancer that would not have caused them problems during their life; equally, some cancers may be missed. That is why we are investing £16 million towards the Prostate Cancer UK-led TRANSFORM programme, which is the name of the screening trial. On health inequalities, as I mentioned earlier, the trial is seeking to find better ways to detect prostate cancer, which is necessary, and to address the health inequalities.

[Baroness Laing of Elderslie (Con)]

My Lords, the Minister mentioned screening for lung cancer, and I am sure the whole House will welcome the progress made in recent years. Can she confirm whether the Government now commit to taking forward the plans for earlier screening of lung cancer, as recommended by the Roy Castle Lung Cancer Foundation?

[Baroness Merron (Lab)]

The Roy Castle Lung Cancer Foundation does excellent work and keeps our minds very focused. The point raised by the noble Baroness will be considered as part of the cancer plan.